Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
24.16
+0.71 (3.03%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Eton Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
65945335511271106
Upgrade
Market Cap Growth
97.44%27.82%215.68%57.54%-32.42%-46.38%
Upgrade
Enterprise Value
664447339966490
Upgrade
Last Close Price
24.1616.9113.324.382.824.29
Upgrade
Forward PE
32.6530.5657.9179.64-9.98
Upgrade
PS Ratio
8.255.679.093.553.364.84
Upgrade
PB Ratio
24.9817.3414.527.265.465.99
Upgrade
P/TBV Ratio
---10.478.577.54
Upgrade
P/FCF Ratio
64.6844.50376.2216.4914.92-
Upgrade
P/OCF Ratio
62.6443.09366.1316.4914.80-
Upgrade
EV/Sales Ratio
8.315.598.693.043.034.11
Upgrade
EV/EBITDA Ratio
74.8550.39----
Upgrade
EV/EBIT Ratio
137.5192.58----
Upgrade
EV/FCF Ratio
65.1943.89359.3214.1113.46-
Upgrade
Debt / Equity Ratio
1.191.191.230.350.500.38
Upgrade
Debt / EBITDA Ratio
3.473.47----
Upgrade
Debt / FCF Ratio
3.053.0531.810.801.36-
Upgrade
Net Debt / Equity Ratio
0.200.200.62-1.03-0.75-0.44
Upgrade
Net Debt / EBITDA Ratio
0.580.58-14.5354.751.516.88
Upgrade
Net Debt / FCF Ratio
0.500.5015.97-2.34-2.041.63
Upgrade
Asset Turnover
0.950.950.721.120.810.81
Upgrade
Inventory Turnover
2.102.101.9314.4212.533.16
Upgrade
Quick Ratio
0.980.981.021.532.814.36
Upgrade
Current Ratio
1.571.572.061.653.105.18
Upgrade
Return on Equity (ROE)
-18.19%-18.19%-19.16%-6.56%-58.75%-11.74%
Upgrade
Return on Assets (ROA)
3.59%3.59%-2.53%-2.63%-19.67%-3.47%
Upgrade
Return on Capital Employed (ROCE)
9.00%9.00%-3.90%-7.70%-44.50%-6.50%
Upgrade
Earnings Yield
-0.70%-1.01%-1.08%-0.83%-12.65%-1.85%
Upgrade
FCF Yield
1.55%2.25%0.27%6.06%6.71%-4.48%
Upgrade
Buyback Yield / Dilution
-3.91%-3.91%-0.97%-1.99%0.24%-19.98%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.